RecruitingPhase 1NCT06653400
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy: a Randomized Controlled Trial
Sponsor
Icahn School of Medicine at Mount Sinai
Enrollment
60 participants
Start Date
Feb 27, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria2
- Patients assigned female at birth,
- booked for office hysteroscopy at Mount Sinai Hospital faculty practice associates.
Exclusion Criteria9
- Allergy to ketorolac or non-steroidal anti-inflammatory medications
- Allergy to lidocaine
- Presence of thrombocytopenia
- Contraindications to lidocaine
- History of gastritis or gastric ulcer
- Acute renal failure or chronic renal disease
- Chronic liver disease
- History of bleeding diathesis
- Long term narcotic use
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREparacervical block
paracervical block with office hysteroscopy
DRUGLidocaine
Dosage: 20 mL of 1% lidocaine
DRUGketorolac
Dosage: 2 mL (30 mg) of ketorolac
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06653400
Related Trials
The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial
NCT074969051 location
Evaluation of Postoperative Pain Control in Ear Surgery
NCT068699671 location
Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population
NCT065592151 location
Liposomal Bupivacaine Versus Ropivacaine for Preperitoneal Infiltration Analgesia in Upper Abdominal Laparotomy
NCT072719791 location
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO
NCT069525561 location